Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BeyondMD vs TeleHealth Med

BeyondMD
Graded #176

Higher grade

vs+0.7000000000000028
TeleHealth Med
Graded #209

Lower grade

The verdict

BeyondMD takes it — 66.8/100 to 66.1/100, but only just.

BeyondMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth clinic offering competitively priced compounded semaglutide and tirzepatide. TeleHealth Med is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBeyondMD +2
76
74
Dose & formulationBeyondMD +1
64
63
Clinical oversightTeleHealth Med +2
74
76
Labs & monitoringBeyondMD +1
53
52
FulfillmentBeyondMD +2
65
63
Contract termsEven
55
55
BeyondMD · left barTeleHealth Med · right bar

The numbers

MetricBeyondMDTeleHealth Med
WeighScore66.8/10066.1/100
GradeCC
Scorecard rank#176#209
Semaglutide$139/mo (starting dose, compounded)$147/mo (starting dose, compounded)
Tirzepatide$209/mo (starting dose, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
BeyondMD

Graded #176 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
TeleHealth Med

Graded #209 · C

Strengths

  • Corporate entity disclosed (TeleHealth Med, Inc.) — clearer accountability than undisclosed competitors
  • Publishes the FDA compounded-medication disclaimer
  • 503A pharmacy designation stated in the FAQ
  • Honest disclosure that testimonials are compensated and results aren't independently verified
  • Both injectable and sublingual forms offered

Where it loses points

  • Specific 503A pharmacy partner not named
  • LegitScript ID number not shown in text — only a verification link
  • Full states-served list not disclosed
  • Named medical director not disclosed
  • Dose tiers beyond the $147/mo starting price not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard